On the examination of 200 embryonal petrous bones the factors affecting the morphology of the tympanic sinus under physiological conditions are discussed. The development of the tympanic sinus begins during the fourth month of embryonic life. In an embryo of 5 months the floor of the tympanic sinus developing between the cochlea and the vestibulum consists of lamellae resembling a wicker basket. Caudally, its floor reaches at first the lower part of the tympanum, for at this stage the styloid prominence and the pavimentum pyramidis are not yet fully developed. In the eighth and ninth month of foetal life the tympanic sinus is narrowed by the styloid prominence, from the floor and from the cranial side it is bordered by the fully developed ponticulus medialis. In postnatal life the development of the membranous bony substance of the promontory, subiculum promontorii and styloid prominence, each narrows the tympanic sinus in some degree. Under the influence of vascular factors highly developed trabeculae and lamellae are formed in them. The cavity is deeper in the dolichocephalics and is more shallow in brachycephalics.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.